Digital breast tomosynthesis in mammographic screening: false negative cancer cases in the To-Be 1 trial

被引：0

作者：

Nataliia Moshina

Axel Gräwingholt

Kristina Lång

Ritse Mann

Tone Hovda

Solveig Roth Hoff

Per Skaane

Christoph I. Lee

Hildegunn S. Aase

Aslak B. Aslaksen

Solveig Hofvind

机构：

[1] Cancer Registry of Norway,Section for Breast Cancer Screening

[2] Mammographiescreening-Zentrum Paderborn,Department of Translational Medicine

[3] Breast Cancer Screening,Department of Medical Imaging

[4] Lund University,Department of Radiology

[5] Radboud University Medical Center,Department of Radiology

[6] the Netherlands Cancer Institute,Department of Radiology

[7] Vestre Viken Hospital Trust,Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences

[8] Ålesund Hospital,Department of Radiology

[9] Møre Og Romsdal Hospital Trust,Department of Radiology

[10] NTNU,Department of Health Systems and Population Health

[11] Oslo University Hospital,Department of Radiology

[12] University of Oslo,Department of Global Public Health and Primary Care, Faculty of Medicine

[13] University of Washington School of Medicine,Department of Health and Care Sciences, Faculty of Health Sciences

[14] University of Washington School of Public Health,undefined

[15] Haukeland University Hospital,undefined

[16] University of Bergen,undefined

[17] UiT,undefined

[18] The Arctic University of Norway,undefined

来源：

Insights into Imaging | / 15卷

关键词：

Mammographic screening; Breast cancer; Digital breast tomosynthesis; Interval cancer; Screen-detected cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 135 条

[1]

Heindel W(2022)Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial Lancet Oncol 23 601-611

[2]

Weigel S(2022)A randomized trial comparing breast cancer incidence and interval cancers after tomosynthesis plus mammography versus mammography alone Radiology 303 256-266

[3]

Gerß J(2018)Digital breast tomosynthesis with synthesized two-dimensional images versus full-field digital mammography for population screening: outcomes from the Verona screening program Radiology 287 37-46

[4]

Pattacini P(2016)Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study Lancet Oncol 17 1105-1113

[5]

Nitrosi A(2021)Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening Eur J Cancer 148 14-23

[6]

Giorgi Rossi P(2021)Interval breast cancer rates and tumor characteristics in the prospective population-based Malmö Breast Tomosynthesis Screening Trial Radiology 299 559-567

[7]

Caumo F(2019)Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (to-be): a randomised, controlled trial Lancet Oncol 20 795-805

[8]

Zorzi M(2021)Interval and subsequent round breast cancer in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography screening Radiology 300 66-76

[9]

Brunelli S(2019)Tomosynthesis in breast screening: great expectations? Lancet Oncol 20 745-746

[10]

Bernardi D(1995)The detectability of breast cancer by screening mammography Br J Cancer 71 337-339

← 1 2 3 4 5 6 7 8 9 10 →